ZA200305345B - 3,7-Diazabicyclo(3.3.0)octanes and their use in the treatment of cardiac arrhythmias. - Google Patents
3,7-Diazabicyclo(3.3.0)octanes and their use in the treatment of cardiac arrhythmias. Download PDFInfo
- Publication number
- ZA200305345B ZA200305345B ZA200305345A ZA200305345A ZA200305345B ZA 200305345 B ZA200305345 B ZA 200305345B ZA 200305345 A ZA200305345 A ZA 200305345A ZA 200305345 A ZA200305345 A ZA 200305345A ZA 200305345 B ZA200305345 B ZA 200305345B
- Authority
- ZA
- South Africa
- Prior art keywords
- compound
- alkyl
- formula
- het
- aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0100326A SE0100326D0 (sv) | 2001-02-02 | 2001-02-02 | New compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200305345B true ZA200305345B (en) | 2004-10-11 |
Family
ID=20282824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200305345A ZA200305345B (en) | 2001-02-02 | 2003-07-10 | 3,7-Diazabicyclo(3.3.0)octanes and their use in the treatment of cardiac arrhythmias. |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US7144914B2 (cs) |
| EP (1) | EP1360187B1 (cs) |
| JP (1) | JP2004522749A (cs) |
| KR (1) | KR20030074764A (cs) |
| CN (2) | CN1854138A (cs) |
| AR (1) | AR035423A1 (cs) |
| AT (1) | ATE298339T1 (cs) |
| BG (1) | BG108035A (cs) |
| BR (1) | BR0206791A (cs) |
| CA (1) | CA2434970A1 (cs) |
| CZ (1) | CZ20032061A3 (cs) |
| DE (1) | DE60204755T2 (cs) |
| EE (1) | EE200300364A (cs) |
| ES (1) | ES2243706T3 (cs) |
| HU (1) | HUP0302538A3 (cs) |
| IL (1) | IL156734A0 (cs) |
| IS (1) | IS6874A (cs) |
| MX (1) | MXPA03006579A (cs) |
| MY (1) | MY136788A (cs) |
| NO (1) | NO20033434L (cs) |
| NZ (1) | NZ526992A (cs) |
| PL (1) | PL363454A1 (cs) |
| PT (1) | PT1360187E (cs) |
| RU (1) | RU2293085C2 (cs) |
| SE (1) | SE0100326D0 (cs) |
| SK (1) | SK9702003A3 (cs) |
| UA (1) | UA75382C2 (cs) |
| WO (1) | WO2002060902A1 (cs) |
| ZA (1) | ZA200305345B (cs) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2440803A1 (en) * | 2001-03-07 | 2002-09-12 | Pfizer Products Inc. | Modulators of chemokine receptor activity |
| PT1761542E (pt) * | 2004-06-09 | 2008-03-26 | Hoffmann La Roche | Derivados de octa-hidro-pirrolo[3,4-c) pirrole e o seu uso com agentes antivirais |
| US7665658B2 (en) | 2005-06-07 | 2010-02-23 | First Data Corporation | Dynamic aggregation of payment transactions |
| GB0514018D0 (en) * | 2005-07-07 | 2005-08-17 | Ionix Pharmaceuticals Ltd | Chemical compounds |
| DK3093291T3 (da) | 2009-10-23 | 2019-07-29 | Janssen Pharmaceutica Nv | Disubstituerede octahy-dropyrrolo [3,4-c]pyrroler som orexinreceptormodulatorer |
| CN102718695B (zh) * | 2012-06-25 | 2014-04-02 | 华东师范大学 | 一种氮杂双环[3.3.0]辛烷衍生物的合成方法 |
| PE20161035A1 (es) | 2013-03-15 | 2016-11-13 | Global Blood Therapeutics Inc | Compuestos y usos de estos para la modulacion de la hemoglobina |
| CA2917050A1 (en) * | 2013-07-03 | 2015-01-08 | Todd K. Jones | Pyrrolo-pyrrole carbamate and related organic compounds, pharmaceutical compositions, and medical uses thereof |
| EA202092627A1 (ru) | 2013-11-18 | 2021-09-30 | Глобал Блад Терапьютикс, Инк. | Соединения и их применения для модуляции гемоглобина |
| AU2017231828B2 (en) | 2016-03-10 | 2022-09-01 | Janssen Pharmaceutica Nv | Methods of treating depression using orexin-2 receptor antagonists |
| EP3468948A1 (en) | 2016-06-08 | 2019-04-17 | GlaxoSmithKline Intellectual Property Development Limited | Chemical compounds |
| MD3483164T2 (ro) | 2017-03-20 | 2020-07-31 | Forma Therapeutics Inc | Compoziții pirolopirolice ca activatori ai piruvat kinazei (PKR) |
| US11001588B2 (en) | 2018-09-19 | 2021-05-11 | Forma Therapeutics, Inc. | Activating pyruvate kinase R and mutants thereof |
| EP3853206B1 (en) | 2018-09-19 | 2024-04-10 | Novo Nordisk Health Care AG | Treating sickle cell disease with a pyruvate kinase r activating compound |
| MX2022003025A (es) | 2019-09-19 | 2022-04-07 | Forma Therapeutics Inc | Activacion de la piruvato cinasa r. |
| RU2726120C1 (ru) * | 2019-09-24 | 2020-07-09 | Федеральное государственное бюджетное научное учреждение Уфимский федеральный исследовательский центр Российской академии наук | N-алкил-n-{ [3-алкил-3,8-диазабицикло[3.2.1]окта-1(7),5-диен-8-ил]метил} амины, обладающие цитотоксической активностью в отношении клеточной линии нек 293 |
| US12128035B2 (en) | 2021-03-19 | 2024-10-29 | Novo Nordisk Health Care Ag | Activating pyruvate kinase R |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU482990A1 (ru) * | 1973-09-03 | 1978-04-15 | Предприятие П/Я Г-4059 | Способ получени 1,4-диазабицикло(2,2,2)-октана |
| DE2428792A1 (de) | 1974-06-14 | 1976-01-02 | Knoll Ag | Neue antiarrhythmika |
| DE3112055A1 (de) | 1981-03-27 | 1982-10-07 | Basf Ag, 6700 Ludwigshafen | Bispidinderivate, ihre herstellung und diese enthaltende arzneimittel |
| DE3234697A1 (de) | 1982-09-18 | 1984-03-22 | Kali-Chemie Pharma Gmbh, 3000 Hannover | Neue diazabicyclo-(3,3,1)-nonane |
| PT88381B (pt) | 1987-09-09 | 1995-07-06 | Kali Chemie Pharma Gmbh | Processo para a preparacao de novos compostos 3,7-diazabiciclo{3,3,1} nonano, e de composicoes farmaceuticas que contem estes compostos |
| DE3732094A1 (de) | 1987-09-24 | 1989-04-06 | Basf Ag | Bispidinderivate als klasse iii-antiarrhythmika |
| DE3930266A1 (de) * | 1989-09-11 | 1991-03-14 | Thomae Gmbh Dr K | Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| US5110933A (en) | 1989-11-13 | 1992-05-05 | Board Of Regents Of Oklahoma State University | Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof |
| US5468858A (en) | 1993-10-28 | 1995-11-21 | The Board Of Regents Of Oklahoma State University Physical Sciences | N-alkyl and n-acyl derivatives of 3,7-diazabicyclo-[3.3.1]nonanes and selected salts thereof as multi-class antiarrhythmic agents |
| DE4338396A1 (de) | 1993-11-10 | 1995-05-11 | Basf Ag | N-Substituierte Azabicycloalkan-Derivate, ihre Herstellung und Verwendung |
| DE4341403A1 (de) | 1993-12-04 | 1995-06-08 | Basf Ag | N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung |
| DE4402931A1 (de) | 1994-02-01 | 1995-08-03 | Kali Chemie Pharma Gmbh | Neue 3-Phenylsulfonyl-3,7-diazabicyclo[3,3,1] nonan-Verbindungen enthaltende Arzneimittel |
| US5457121A (en) | 1994-09-02 | 1995-10-10 | Eli Lilly And Company | Cis-hexahydro-5-(1,2,3,4-tetrahydro-2-naphthalenyl)pyrrolo<3,4-c>pyrroles as inhibitors of serotonin reuptake |
| ES2207657T3 (es) * | 1995-02-27 | 2004-06-01 | F. Hoffmann-La Roche Ag | Pirrolderivados de dioxopirrolo. |
| EP0828741B1 (en) | 1995-05-11 | 2001-08-29 | PHARMACIA & UPJOHN COMPANY | Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones |
| IL122296A0 (en) * | 1995-06-06 | 1998-04-05 | Abbott Lab | Quinolizinone type compounds |
| PT1019385E (pt) | 1995-09-15 | 2004-06-30 | Upjohn Co | N-oxidos de aminoaril-oxazolidinona |
| GB9519563D0 (en) * | 1995-09-26 | 1995-11-29 | Merck Sharp & Dohme | Therapeutic agents |
| ATE228137T1 (de) | 1996-08-13 | 2002-12-15 | Merck & Co Inc | Palladiumkatalysierte indolisierung |
| US5808064A (en) * | 1996-08-13 | 1998-09-15 | Merck & Co., Inc. | Palladium catalyzed indolization |
| SE9704709D0 (sv) | 1997-12-17 | 1997-12-17 | Astra Ab | Pharmaceutically active compounds |
| US6355641B1 (en) * | 1999-03-17 | 2002-03-12 | Syntex (U.S.A.) Llc | Oxazolone derivatives and uses thereof |
| RU2160738C2 (ru) * | 1999-03-29 | 2000-12-20 | ООО Научно-производственное предприятие "Новые технологии" | Способ получения 1,4-диазобицикло [2,2,2]октана |
| DE19932621A1 (de) * | 1999-07-13 | 2001-04-26 | Bayer Ag | Neue substituerte alpha, beta-anellierte Butyrolactone |
| MY145722A (en) * | 2000-04-27 | 2012-03-30 | Abbott Lab | Diazabicyclic central nervous system active agents |
| US6890938B2 (en) * | 2000-11-20 | 2005-05-10 | Scios, Inc. | Indole-type inhibitors of p38 kinase |
-
2001
- 2001-02-02 SE SE0100326A patent/SE0100326D0/xx unknown
-
2002
- 2002-01-25 AR ARP020100275A patent/AR035423A1/es not_active Application Discontinuation
- 2002-01-29 PT PT02716531T patent/PT1360187E/pt unknown
- 2002-01-29 BR BR0206791-9A patent/BR0206791A/pt not_active IP Right Cessation
- 2002-01-29 AT AT02716531T patent/ATE298339T1/de not_active IP Right Cessation
- 2002-01-29 CA CA002434970A patent/CA2434970A1/en not_active Abandoned
- 2002-01-29 HU HU0302538A patent/HUP0302538A3/hu unknown
- 2002-01-29 CN CNA2006100847244A patent/CN1854138A/zh active Pending
- 2002-01-29 PL PL02363454A patent/PL363454A1/xx not_active Application Discontinuation
- 2002-01-29 CN CNB028044126A patent/CN1263758C/zh not_active Expired - Fee Related
- 2002-01-29 ES ES02716531T patent/ES2243706T3/es not_active Expired - Lifetime
- 2002-01-29 EP EP02716531A patent/EP1360187B1/en not_active Expired - Lifetime
- 2002-01-29 RU RU2003121308/04A patent/RU2293085C2/ru not_active IP Right Cessation
- 2002-01-29 UA UA2003076389A patent/UA75382C2/uk unknown
- 2002-01-29 JP JP2002561470A patent/JP2004522749A/ja active Pending
- 2002-01-29 SK SK970-2003A patent/SK9702003A3/sk unknown
- 2002-01-29 WO PCT/SE2002/000152 patent/WO2002060902A1/en not_active Ceased
- 2002-01-29 CZ CZ20032061A patent/CZ20032061A3/cs unknown
- 2002-01-29 EE EEP200300364A patent/EE200300364A/xx unknown
- 2002-01-29 DE DE60204755T patent/DE60204755T2/de not_active Expired - Fee Related
- 2002-01-29 KR KR10-2003-7010119A patent/KR20030074764A/ko not_active Ceased
- 2002-01-29 US US10/467,043 patent/US7144914B2/en not_active Expired - Fee Related
- 2002-01-29 MX MXPA03006579A patent/MXPA03006579A/es active IP Right Grant
- 2002-01-29 NZ NZ526992A patent/NZ526992A/en unknown
- 2002-01-29 IL IL15673402A patent/IL156734A0/xx unknown
- 2002-01-31 MY MYPI20020360A patent/MY136788A/en unknown
-
2003
- 2003-07-10 ZA ZA200305345A patent/ZA200305345B/en unknown
- 2003-07-11 IS IS6874A patent/IS6874A/is unknown
- 2003-07-28 BG BG108035A patent/BG108035A/bg unknown
- 2003-08-01 NO NO20033434A patent/NO20033434L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200305345B (en) | 3,7-Diazabicyclo(3.3.0)octanes and their use in the treatment of cardiac arrhythmias. | |
| AU2019302534B2 (en) | Pyridazine compounds for inhibiting NaV1.8 | |
| EP2794600B1 (en) | 2,3-Dihydro-benzo[1,4]oxazine derivatives and related compounds as phosphoinositide-3 kinase (PI3K) inhibitors for the treatment of e.g. rheumatoid arthritis | |
| CN105503862B (zh) | 流感病毒复制抑制剂 | |
| AU2008275735B2 (en) | Tetrahydropyranochromene gamma secretase inhibitors | |
| TWI466886B (zh) | 二氮雜咔唑及使用方法 | |
| EP3074402B1 (en) | Bicycloamine-substituted-n-benzenesulfonamide compounds with selective activity in voltage-gated sodium channels | |
| EP2911668A1 (en) | Benzoxazolinone compounds with selective activity in voltage-gated sodium channels | |
| EP3651752A1 (en) | Carboxamides as modulators of sodium channels | |
| HK1226064A1 (zh) | 作为trpm8拮抗剂的氮杂螺衍生物 | |
| WO2007056468A1 (en) | Methods for inhibiting protein kinases | |
| AU2014287471A1 (en) | Fused piperidine amides as modulators of ion channels | |
| TW202035412A (zh) | 雜芳基二氫嘧啶衍生物和治療ｂ型肝炎感染之方法 | |
| WO2023232135A1 (zh) | Pde4b抑制剂及其用途 | |
| EP3774736B1 (en) | Compounds as modulators of tlr2 signaling | |
| JP2014511355A (ja) | ヒストンデアセチラーゼ阻害薬並びにその組成物及び使用方法 | |
| CN114025847A (zh) | 作为tlr信号传导的调节剂的化合物和组合物 | |
| JP2020502089A (ja) | 化合物、組成物および方法 | |
| WO2023194458A1 (en) | N-(3-(benzo[b]thiophene-2-carboxamido)-phenyl)-2,3-dihydrobenzo[b][1,4]dioxine-6-carboxamide derivatives and related compounds as lactate/atp production inhibitors for the treatment of cancer | |
| CN105745214B (zh) | 三环哌啶化合物 | |
| CN105745211A (zh) | 作为色氨酸羟化酶的抑制剂的三环咪唑化合物 | |
| WO2002053568A1 (en) | Cholesterol biosynthesis inhibitors containing as the active ingredient tricyclic spiro compounds | |
| AU2024206583A1 (en) | Pyridazinone heterocyclic compound myosin ii inhibitor and use thereof | |
| JP6545908B2 (ja) | 三環式化合物、及び癌治療におけるそれらの使用 | |
| TW201422625A (zh) | 二氫－吡啶并－□衍生物之固體形式 |